Physician profile
Robin Osofsky
NPI 1457715286
$2,456.56
in general payments reported to CMS, 2019-2025
8 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $378 · 2024: $887 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,890 · Education: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,889.94 |
| Education | $566.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,315.29 | 2023-2025 | Endurant Iis, In.Pact Admiral, Protege Rx |
| Stryker Corporation | $300.93 | 2025 | Clottriever Bold Catheter |
| Inari Medical, INC. | $229.13 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Silk Road Medical, INC. | $171.38 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Inspiremd Ltd | $166.71 | 2025 | Cguard Prime Carotid Stent System |
| Penumbra, INC. | $121.75 | 2025 | Indigo System |
| W. L. Gore & Associates, INC. | $113.00 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Terumo Medical Corporation | $38.37 | 2025 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Osofsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.